MX2021011628A - Composiciones de biopelícula probiótica y métodos para prepararlas. - Google Patents

Composiciones de biopelícula probiótica y métodos para prepararlas.

Info

Publication number
MX2021011628A
MX2021011628A MX2021011628A MX2021011628A MX2021011628A MX 2021011628 A MX2021011628 A MX 2021011628A MX 2021011628 A MX2021011628 A MX 2021011628A MX 2021011628 A MX2021011628 A MX 2021011628A MX 2021011628 A MX2021011628 A MX 2021011628A
Authority
MX
Mexico
Prior art keywords
methods
preparing same
biofilm compositions
probiotic biofilm
probiotic
Prior art date
Application number
MX2021011628A
Other languages
English (en)
Spanish (es)
Inventor
David Daboush
Dorit Rozner
Stephanie Cohen
Hila Elyahu
Original Assignee
Mybiotics Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/368,030 external-priority patent/US10709744B1/en
Application filed by Mybiotics Pharma Ltd filed Critical Mybiotics Pharma Ltd
Publication of MX2021011628A publication Critical patent/MX2021011628A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2021011628A 2019-03-28 2020-03-29 Composiciones de biopelícula probiótica y métodos para prepararlas. MX2021011628A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16/368,030 US10709744B1 (en) 2019-03-28 2019-03-28 Probiotic biofilm suppositories
US201962827931P 2019-04-02 2019-04-02
PCT/IL2020/050380 WO2020194319A1 (en) 2019-03-28 2020-03-29 Probiotic biofilm compositions and methods of preparing same

Publications (1)

Publication Number Publication Date
MX2021011628A true MX2021011628A (es) 2021-12-10

Family

ID=72610340

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021011628A MX2021011628A (es) 2019-03-28 2020-03-29 Composiciones de biopelícula probiótica y métodos para prepararlas.

Country Status (11)

Country Link
EP (1) EP3946392A4 (ja)
JP (1) JP2022535323A (ja)
KR (1) KR20220016042A (ja)
CN (1) CN113766923A (ja)
AU (1) AU2020250170A1 (ja)
BR (1) BR112021019437A2 (ja)
CA (1) CA3131165A1 (ja)
IL (1) IL286704A (ja)
MX (1) MX2021011628A (ja)
SG (1) SG11202110741YA (ja)
WO (1) WO2020194319A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023195008A1 (en) * 2022-04-05 2023-10-12 Mybiotics Pharma Ltd. Bacterial compositions and methods for growing bacteria on particles

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2009092810A2 (en) * 2008-01-24 2009-07-30 Bacterfield Oü Single pharmaceutical composition containing antibiotics and probiotics
US20120247993A1 (en) * 2008-11-14 2012-10-04 Unistraw Patent Holdings Limited Probiotic Compositions, Methods and Apparatus for Their Administration
IT1400821B1 (it) * 2009-03-09 2013-07-02 Probiotical Spa Sospensione oleosa contenente batteri probiotici per uso pediatrico
ITMI20120131A1 (it) * 2012-02-01 2013-08-02 Probiotical Spa Batteri probiotici microincapsulati multistrato, loro produzione ed uso
JP6754694B2 (ja) * 2014-03-06 2020-09-16 リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル プロバイオティクス製剤および使用のための方法
WO2016181228A2 (en) * 2015-05-11 2016-11-17 Mybiotix Pharma Ltd. Systems and methods for growing a biofilm of probiotic bacteria on solid particles for colonization of bacteria in the gut
AU2016353091B2 (en) * 2015-11-10 2022-07-14 Probiotech Llc Probiotic delivery systems
WO2017095968A1 (en) * 2015-11-30 2017-06-08 Imagilin Technology Llc Compositions comprising probiotics and methods of use thereof
KR101784847B1 (ko) * 2016-05-10 2017-10-13 주식회사 하우동천 질염 예방 및 치료용 유산균 함유 조성물 및 이의 용도
US11297868B2 (en) * 2016-05-29 2022-04-12 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Method of generating bacterial compositions
US11260086B2 (en) * 2016-07-11 2022-03-01 The Brigham And Women's Hospital, Inc. Medicinal vaginal lactobacillus cocktail
WO2019136391A1 (en) * 2018-01-05 2019-07-11 Human Longevity, Inc. Probiotic compositions comprising bacteria from bacteroids and firmicutes phyla

Also Published As

Publication number Publication date
EP3946392A1 (en) 2022-02-09
EP3946392A4 (en) 2022-12-07
JP2022535323A (ja) 2022-08-08
WO2020194319A1 (en) 2020-10-01
KR20220016042A (ko) 2022-02-08
CA3131165A1 (en) 2020-10-01
BR112021019437A2 (pt) 2021-11-30
CN113766923A (zh) 2021-12-07
AU2020250170A1 (en) 2021-10-28
SG11202110741YA (en) 2021-10-28
IL286704A (en) 2021-10-31

Similar Documents

Publication Publication Date Title
MX2021010160A (es) Preparaciones de membrana bacteriana.
NZ727449A (en) Inoculants and methods for use thereof
PH12019501780A1 (en) Microbial cells, methods of producing the same, and uses thereof
PH12021550676A1 (en) Plant inoculation method
MX2022001534A (es) Composiciones de probioticos a base de plantas fermentadas y procesos de preparacion de las mismas.
AU2018282018A1 (en) Compositions and methods for reducing flatulence
MX2018002307A (es) Bacteria lactobacillus fermentum que reduce la concentracion de acetaldehido.
PH12019550231A1 (en) Probiotic bacteria preconditioned in a gos-containing medium and use thereof
MX2022001428A (es) Metodos y composiciones para cultivar bacterias dependientes de hemoglobina.
MX2022001449A (es) Compuestos de aminoesterol humano ent-03, composiciones relacionadas que comprenden los mismos y metodos para usar los mismos.
PH12017500971A1 (en) Synergistic bacterial consortia for mobilizing soil phosphorus
MX2021014949A (es) Recubrimientos resistentes a la incrustación biológica y métodos para elaborar y usar los mismos.
WO2020146700A8 (en) Lipid nanoparticles
MX2021011628A (es) Composiciones de biopelícula probiótica y métodos para prepararlas.
MX2021014202A (es) Metodos y composiciones para la fermentacion bacteriana anaerobia.
IL280282A (en) Microorganisms with increased lipid production, preparations and methods for their preparation and use
MX2021009443A (es) Composiciones que contienen bacterias productoras de bacillaeno o preparaciones de las mismas.
MX2021006808A (es) Novedosa psicosa-6-fosfato fosfatasa, composicion para la produccion de psicosa que comprende la misma y procedimiento para la produccion de psicosa mediante el uso de la misma.
MX2019005535A (es) Streptococcus thermophilus para uso en la preparación de productos fermentados.
MX2021008983A (es) Atributos de aflibercept y metodos de caracterizacion y modificacion de los mismos.
MX2023010484A (es) Composiciones de cemento y métodos de estas.
MX2023006512A (es) Método para preparar pralsetinib.
WO2020180736A3 (en) Production of cannabinoids using genetically engineered photosynthetic microorganisms
MX2021015879A (es) Peptidos restringidos.
WO2018083314A3 (en) Use of phenothiazine derivative in the treatment of infectious purpura or purpura fulminans